Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Neratinib Efficacy in Patients With EGFR Exon 18-Mutant Non-Small-Cell Lung Cancer: Findings From the SUMMIT Basket Trial

Clinical Lung Cancer(2024)10.1016/j.cllc.2024.12.003Source: DataRank Database

Neratinib Efficacy in Patients With EGFR Exon 18-Mutant Non-Small-Cell Lung Cancer: Findings From the SUMMIT Basket Trial is a research paper published in Clinical Lung Cancer (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.10)OA: hybridTopics (36)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

A. Martinez Bueno ORCID,Christophe Dooms ORCID,Komal Jhaveri ORCID,Maria de Miguel,Sarina A. Piha‐Paul ORCID

Live enrichment

PubMed:39828466 OpenAlex:https://openalex.org/W4405283974

Puma Biotechnology

Grant: P30CA016672

National Cancer Institute

National Institutes of Health

FWCI

1.10

Citation Percentile

0.8%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttp://www.clinical-lung-cancer.com/article/S1525730424002663/pdf

HYBRIDhttp://www.clinical-lung-cancer.com/article/S1525730424002663/pdf

publisherhttp://www.clinical-lung-cancer.com/article/S1525730424002663/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1525730424002663?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525730424002663?httpAccept=text/plain

Fields of Study

Lung Cancer Treatments and MutationsHER2/EGFR in Cancer ResearchLung Cancer Research StudiesMedicine

MeSH Terms

AdultAgedAged, 80 and overCarcinoma, Non-Small-Cell LungExonsFemaleHumansLung NeoplasmsMaleMiddle AgedMutationQuinolinesSurvival RateProtein Kinase InhibitorsErbB Receptors

Keywords

MedicineNeratinibInternal medicineClinical endpointLung cancerOncologyDiarrheaTyrosine-kinase inhibitorGastroenterologyCancerClinical trialTrastuzumabNSCLCTyrosine kinase inhibitorRare MutationsObjective Response RateBasket Study

Sustainable Development Goals

SDG 0: Zero hunger